STAT3 and Cachexia: Accumulating evidence suggests that IL-6 and other members of the IL-6 family that activate STAT3, such as IL-11, leukemia inhibitory factor, oncostatin M and ciliary neurotrophic factor, play an important role in the development and progression of cachexia and have increasingly been implicated in the molecular mechanisms of muscle atrophy.